Celyad SA – American Depositary Shares (NASDAQ:CYAD) Sellers Strengthened By 51.81% Their Shorts

April 16, 2018 - By Nadine Davis

Celyad SA (NASDAQ:CYAD) Corporate Logo

Celyad SA – American Depositary Shares (NASDAQ:CYAD) noted an increase of 51.81% in shares shorted. FINRA announced in April CYAD’s total 125,700 shares shorted. The 82,800 previous shares are up with 51.81%. 14 days will cost CYAD With 8,700 average volume to recover its previous position. 1.91% is Celyad SA – American Depositary Shares float short.

On during the last trading session the stock increased $0.0512 or 0.16%, reaching $31.4312.Currently Celyad SA is after 0.00% change in last April 16, 2017. CYAD has 1,045 shares volume. CYAD underperformed the S&P500 by 11.55%.

Celyad SA, a biopharmaceutical company, focuses on engineered cell therapy treatments.The firm is worth $318.33 million. It operates in two divisions, Cardiology and Immuno-oncology.Currently it has negative earnings. The companyÂ’s lead product candidate in cardiovascular disease is C-Cure, an autologous cell therapy for the treatment of patients with ischemic heart failure.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: